The Medical Science Liaison (MSL) will represent the Company and its Neurology/Epilepsy portfolio approved product and portfolio.
The MSL will build long term peer to peer relationships with thought leaders, payers and other stakeholders within the CNS community to deliver clinical, scientific, and technical education on the role of Lennox-Gastaut Syndrome (LGS). The MSL is responsible for cultivating and maintaining collaborative relationships with influential members of the medical community to promote company, disease state and therapeutic awareness, in addition to serving as an advanced technical, scientific, and medical expert in CNS/Epilepsy for the assigned region. The MSL is responsible for developing, coordinating and assuring implementation of the Company’s corporate, scientific, and clinical strategies with these thought leaders within academic, clinical, and healthcare organizations. These scientific exchanges will support and/or expand current therapeutic concepts, as well as ensure the safe and effective utilization of the Company’s product(s).
Additionally, the MSL will support the Company’s research initiatives and investigator-initiated clinical trials and participate in and contribute to projects and initiatives that increase the value and productivity of the Medical Affairs team.